First-line treatment with imatinib mesylate in patients with chronic phase chronic myeloid leukemia: experience of a public hospital in a developing country of South America

Saved in:
Bibliographic Details
Published in:Leukemia & lymphoma 2012-07, Vol.53 (7), p.1417-1419
Main Authors: da Silveira, Carlos Alberto Pinto, Ferrari, Iris
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Aged, 80 and over
Benzamides
Brazil
Disease Progression
Disease-Free Survival
Female
Fusion Proteins, bcr-abl - genetics
Hospitals, Public
Humans
Imatinib Mesylate
Leukemia, Myeloid, Chronic-Phase - diagnosis
Leukemia, Myeloid, Chronic-Phase - drug therapy
Leukemia, Myeloid, Chronic-Phase - genetics
Male
Middle Aged
Piperazines - therapeutic use
Protein Kinase Inhibitors - therapeutic use
Pyrimidines - therapeutic use
Transcription, Genetic - drug effects
Treatment Outcome
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1042-8194
1029-2403
DOI:10.3109/10428194.2011.653641